NO20060775L - Muskarine acetylkolinreseptorantagonister - Google Patents
Muskarine acetylkolinreseptorantagonisterInfo
- Publication number
- NO20060775L NO20060775L NO20060775A NO20060775A NO20060775L NO 20060775 L NO20060775 L NO 20060775L NO 20060775 A NO20060775 A NO 20060775A NO 20060775 A NO20060775 A NO 20060775A NO 20060775 L NO20060775 L NO 20060775L
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonists
- acetylcholine receptor
- muscarine
- muscarine acetylcholine
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48798103P | 2003-07-17 | 2003-07-17 | |
PCT/US2004/022947 WO2005009439A1 (en) | 2003-07-17 | 2004-07-16 | Muscarinic acetylcholine receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060775L true NO20060775L (no) | 2006-04-11 |
Family
ID=34102735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060775A NO20060775L (no) | 2003-07-17 | 2006-02-17 | Muskarine acetylkolinreseptorantagonister |
Country Status (21)
Country | Link |
---|---|
US (1) | US20060178395A1 (es) |
EP (1) | EP1648460A4 (es) |
JP (1) | JP2007523877A (es) |
KR (1) | KR20060063890A (es) |
CN (1) | CN1822838A (es) |
AP (1) | AP2006003478A0 (es) |
AR (1) | AR045913A1 (es) |
AU (1) | AU2004259232A1 (es) |
BR (1) | BRPI0412716A (es) |
CA (1) | CA2532375A1 (es) |
EA (1) | EA200600267A1 (es) |
EC (1) | ECSP056254A (es) |
IL (1) | IL172822A0 (es) |
IS (1) | IS8302A (es) |
MA (1) | MA27900A1 (es) |
MX (1) | MXPA06000662A (es) |
NO (1) | NO20060775L (es) |
PE (1) | PE20050327A1 (es) |
TW (1) | TW200523261A (es) |
UY (1) | UY28417A1 (es) |
WO (1) | WO2005009439A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR045914A1 (es) * | 2003-07-17 | 2005-11-16 | Glaxo Group Ltd | Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima |
DK1677795T3 (da) | 2003-10-14 | 2011-04-18 | Glaxo Group Ltd | Muskarine acetylcholin-receptor-antagonister |
EA200600787A1 (ru) * | 2003-10-17 | 2006-08-25 | Глэксо Груп Лимитед | Антагонисты мускариновых ацетилхолиновых рецепторов |
TW200524577A (en) * | 2003-11-04 | 2005-08-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
EP1725236A4 (en) * | 2004-03-11 | 2009-05-13 | Glaxo Group Ltd | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS |
EP1725564A4 (en) * | 2004-03-17 | 2007-09-12 | Glaxo Group Ltd | ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR |
WO2005094251A2 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3muscarinic acetylcholine receptor antagonists |
MY144753A (en) | 2004-04-27 | 2011-10-31 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
JP2007537261A (ja) * | 2004-05-13 | 2007-12-20 | グラクソ グループ リミテッド | ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2006055553A2 (en) * | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
TWI268704B (en) * | 2005-06-28 | 2006-12-11 | Realtek Semiconductor Corp | Apparatus and method for detecting vertical blanking interval |
WO2007016650A2 (en) * | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
AR070564A1 (es) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | Derivados de 1h-pirazolo[3,4-b]piridin-5-ilo,inhibidores de fosfodiesterasas pde4 y antagonistas de receptores muscarinicos de acetilcolina(machr), utiles en el tratamiento y/o profilaxis de enfermedades respiratorias y alergicas,y composiciones farmaceuticas que los comprenden |
TW201000476A (en) | 2008-02-06 | 2010-01-01 | Glaxo Group Ltd | Dual pharmacophores-PDE4-muscarinic antagonistics |
CL2009000249A1 (es) | 2008-02-06 | 2009-09-11 | Glaxo Group Ltd | Compuestos derivados de pirazolo[3,4-b] piridin-butanodiamida; composicion farmaceutica; y su uso en el tratamiento del asma, enfermedad pulmonar obstructiva cronica, rinitis, dermatitis atopica, psoriasis. |
WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
WO2012051426A2 (en) * | 2010-10-15 | 2012-04-19 | Glaxo Group Limited | Aggregate nanoparticulate medicament formulations, manufacture and use thereof |
US9763965B2 (en) | 2012-04-13 | 2017-09-19 | Glaxosmithkline Intellectual Property Development Limited | Aggregate particles |
CA3173172A1 (en) | 2020-03-26 | 2021-09-30 | Christopher D. Kane | Cathepsin inhibitors for preventing or treating viral infections |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2800478A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
US2800482A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
US2800481A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
WO1998024788A1 (en) * | 1996-12-02 | 1998-06-11 | Georgetown University | Tropane derivatives and method for their synthesis |
US6248752B1 (en) * | 1998-02-27 | 2001-06-19 | Charles Duane Smith | Azabicyclooctane compositions and methods for enhancing chemotherapy |
US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
WO2000066586A1 (en) * | 1999-05-04 | 2000-11-09 | Neurosearch A/S | Heteroaryl diazabicycloalkanes, their preparation and use |
ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
AU2001271027B2 (en) * | 2000-07-11 | 2005-07-07 | Msd K.K. | Ester derivatives |
PL370087A1 (en) * | 2001-10-17 | 2005-05-16 | Ucb, S.A. | Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
ES2329586T3 (es) * | 2003-11-21 | 2009-11-27 | Theravance, Inc. | Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino. |
-
2004
- 2004-07-15 UY UY28417A patent/UY28417A1/es not_active Application Discontinuation
- 2004-07-15 PE PE2004000673A patent/PE20050327A1/es not_active Application Discontinuation
- 2004-07-15 TW TW093121062A patent/TW200523261A/zh unknown
- 2004-07-15 AR ARP040102498A patent/AR045913A1/es unknown
- 2004-07-16 WO PCT/US2004/022947 patent/WO2005009439A1/en active Application Filing
- 2004-07-16 AU AU2004259232A patent/AU2004259232A1/en not_active Abandoned
- 2004-07-16 US US10/565,046 patent/US20060178395A1/en not_active Abandoned
- 2004-07-16 JP JP2006520377A patent/JP2007523877A/ja not_active Withdrawn
- 2004-07-16 EA EA200600267A patent/EA200600267A1/ru unknown
- 2004-07-16 CN CNA2004800206494A patent/CN1822838A/zh active Pending
- 2004-07-16 KR KR1020067001000A patent/KR20060063890A/ko not_active Application Discontinuation
- 2004-07-16 AP AP2006003478A patent/AP2006003478A0/xx unknown
- 2004-07-16 CA CA002532375A patent/CA2532375A1/en not_active Abandoned
- 2004-07-16 EP EP04778451A patent/EP1648460A4/en not_active Withdrawn
- 2004-07-16 BR BRPI0412716-1A patent/BRPI0412716A/pt not_active IP Right Cessation
- 2004-07-16 MX MXPA06000662A patent/MXPA06000662A/es unknown
-
2005
- 2005-12-26 IL IL172822A patent/IL172822A0/en unknown
- 2005-12-27 EC EC2005006254A patent/ECSP056254A/es unknown
-
2006
- 2006-01-06 MA MA28704A patent/MA27900A1/fr unknown
- 2006-02-14 IS IS8302A patent/IS8302A/is unknown
- 2006-02-17 NO NO20060775A patent/NO20060775L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20060063890A (ko) | 2006-06-12 |
MXPA06000662A (es) | 2006-03-30 |
EP1648460A1 (en) | 2006-04-26 |
EP1648460A4 (en) | 2009-04-01 |
CN1822838A (zh) | 2006-08-23 |
IS8302A (is) | 2006-02-14 |
WO2005009439A1 (en) | 2005-02-03 |
UY28417A1 (es) | 2005-02-28 |
AP2006003478A0 (en) | 2006-02-28 |
JP2007523877A (ja) | 2007-08-23 |
TW200523261A (en) | 2005-07-16 |
AU2004259232A1 (en) | 2005-02-03 |
ECSP056254A (es) | 2006-04-19 |
CA2532375A1 (en) | 2005-02-03 |
EA200600267A1 (ru) | 2006-06-30 |
MA27900A1 (fr) | 2006-05-02 |
BRPI0412716A (pt) | 2006-09-26 |
US20060178395A1 (en) | 2006-08-10 |
AR045913A1 (es) | 2005-11-16 |
IL172822A0 (en) | 2006-06-11 |
PE20050327A1 (es) | 2005-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060775L (no) | Muskarine acetylkolinreseptorantagonister | |
NO20060776L (no) | Muskarine acetylkolinreseptorantagonister | |
NO20065417L (no) | Muskarine acetylkolinreceptorantagonister | |
NO20060777L (no) | Muskarine acetylkolinreseptorantagonister | |
NO20062042L (no) | Muskariniske acetylkolin reseptorantangonister | |
UY28598A1 (es) | Antagonistas de receptores de acetilcolina muscarinicos | |
UY27927A1 (es) | Antagonistas del receptor muscarínico m3 de acetilcolina | |
NO20063032L (no) | Nye M3 muskarinacetylkolinreceptorantagoniser | |
BRPI0506777A (pt) | antagonistas do receptor muscarìnico da acetilcolina | |
NO20062992L (no) | Nye M3 muskarine acetykolinreseptorantagonister | |
NO20062071L (no) | Muskariniske acetylkolin-reseptorantangonister | |
TR200300322T2 (tr) | Kemokin alıcısını bağlayan heterosiklik bileşikler | |
TW200600093A (en) | M3 muscarinic acetylcholine receptor antagonists | |
EA200702278A1 (ru) | Антитела, специфичные в отношении tgf-бета 1 | |
TW200606161A (en) | Muscarinic acetylcholine receptor antagonists | |
WO2007022351A3 (en) | Muscarinic acetylcholine receptor antagonists | |
TW200600500A (en) | M3 muscarinic acetylcholine receptor antagonists | |
WO2007016650A3 (en) | M3 muscarinic acetylcholine receptor antagonists | |
ATE399777T1 (de) | Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptors | |
DE60305026D1 (de) | 3,4-dihydrochinolin-2(1h)-on verbindungen als nr2b rezeptor antagonisten | |
DE602006010187D1 (de) | Einzelsequenzhybridisierungssonden | |
NO20080409L (no) | Fremgangsmater og preparater til malsoking av IFNAR2 | |
UY28557A1 (es) | Antagonistas de receptores de acetilcolina muscarinicos | |
ES1057531Y (es) | Maquina herramienta trifuncional independiente. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |